Brand Medic Pharmacy Prescription Blood Thinner Can Reduce The Risk Of Blood Clots

People who take the Canadian blood thinner Warfarin and monitor their blood while adjusting their dosage can reduce the risk of blood clots by 50 percent.

if you need marevan tablet in pakistan so now visit our online pharmacy and order book and get free delivery within 1 to 2 days from tcs express courier

“The concept of self-care and self-monitoring is a growing part of health care, it is widely used in the management of diabetes, asthma and hypertension,” said lead researcher Dr. Carl Heneghan University of Oxford.

“Evidence suggests that self-monitoring is an effective strategy for reducing thromboembolic events in patients receiving oral anticoagulants such as marevan 5mg,” he said.

“In Germany, 20 percent of warfarin recipients check their blood and adjust their dose accordingly, compared to about 1 percent of similar patients in the United States,” the researchers said.

Dr. from the Department of Internal Medicine of the Medical University of Vienna and co-author of the editorship of the accompanying journal. “The effect of self-control is not the same for all patient groups,” said Paul Alexander Kyrle.

“While patients with mechanical heart valves benefit, particularly men younger than 55, other patient groups, including those with atrial fibrillation, do not,” he said.

“Now there are new oral anticoagulants on the market that are at least as safe and effective as warfarin, and they don’t require regular coagulation monitoring. So many patients with atrial fibrillation will switch from marevan 5mg to new agents in the near future,” said Kyrle. In addition, these new drugs are easily available at Brand online pharmacy in pakistan.

Another expert, associate professor of cardiology at the University of California in Los Angeles, Dr. “Newer drugs such as rivaroxaban (Xarelto), apixaban (Eliquis), and dabigatran (Pradaxa) provide safe and effective anticoagulation without the need for any blood tests,” he said. “Many patients requiring anticoagulation will find these new oral agents to be the most attractive option,” Fonarow said.

Leave a Reply

Your email address will not be published. Required fields are marked *